Renal cell carcinoma: a priority malignancy for development and study of novel therapies.
Motzer
Robert J
RJ
D002292:Carcinoma, Renal Cell / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000628:therapy*; D009362:Neoplasm Metastasis; D009392:Nephrectomy; D016032:Randomized Controlled Trials as Topic
D016898:Interferon-alpha; D007376:Interleukin-2